Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1376503 | Bioorganic & Medicinal Chemistry Letters | 2006 | 4 Pages |
Abstract
A series of ionizable prolyl oligopeptidase inhibitors were developed through the introduction of a pyridyl group to the P3 position of the prolyl oligopeptidase inhibitor structure. The study was performed on previously developed prolyl oligopeptidase inhibitors with proline mimetics at the P2 position. The 3-pyridyl group resulted in equipotent compounds as compared to the parent compounds. It was shown that the pyridyl group improves water solubility and, in combination with a 5(R)-tert-butyl-l-prolyl group at the P2 position, good lipophilicity can be achieved.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Elina M. Jarho, Jarkko I. Venäläinen, Juha Juntunen, A. Leena Yli-Kokko, Jouko Vepsäläinen, Johannes A.M. Christiaans, Markus M. Forsberg, Tomi Järvinen, Pekka T. Männistö, Erik A.A. Wallén,